Araclon We are thrilled to announce our participation in the upcoming AD/PD 2025 Congress in Vienna (April 1-5) // Join us at AD/PD2025 Congress in Vienna (April 1-5) This hybrid event will unite experts and leaders from the health, neuroscience, and biotechnology sectors to discuss the latest advancements in neurodegenerative diseases such as Alzheimer’s and Parkinson’s, … Read more
What is ABvac40? ABvac40 is a vaccine developed to prevent Alzheimer’s disease from its earliest stages. Phase 2 clinical studies have shown promising results, indicating that the vaccine is safe and capable of generating a strong and sustained immune response over time. In addition, some patients have experienced some cognitive benefits, although these findings need … Read more
